Table 2 Clinical indications for CRS and HIPEC
| Clinical indication | Number | Percentage |
|---|---|---|
| Carcinoma of the ovary | 131 | 56.5% |
| Pseudomyxoma peritonei | 43 | 18.5% |
| Colorectal cancer | 31 | 13.4% |
| Malignant mesothelioma | 13 | 5.6% |
| Gastric carcinoma | 6 | 2.6% |
| Endometrial stromal sarcoma | 5 | 2.2% |
| Granulosa cell tumor | 3 | 1.3% |